Navigation Links
RNase Inhibitor (Cloned) from Ambion

ProductsRNase Inhibitor (Cloned) from Ambion
Company Ambion
Item RNase Inhibitor (Cloned)
Price $94.00
Description Ambion's RNase Inhibitor is a recombinant human protein produced in E. coli and is a potent inhibitor of neutral pancreatic RNase A type enzymes. The mode of inhibition is noncompetitive; the inhibitor tightly binds RNases in a 1:1 ratio. The enzyme has been shown to inactivate RNases present in many tissues and cell types. Addition of the ribonuclease inhibitor has been shown to be useful whenever the integrity of RNA must be maintained such as in the preparation of cDNA by reverse transcription, in vitro RNA transcription and in in vitro protein synthesis, and RNA isolation and preparation of RNase-free antibodies. Ribonuclease inhibitor does not inhibit RNase 1, T1, T2, H, U1, U2 or CL3. Ribonuclease inhibitor requires a minimum of 1 mM DTT to maintain activity, and has an activity range between pH 5.0 to 8.0 with maximal activity between pH 7.0 and 8.0.
Info AmbionAmbion
2130 Woodward
Austin, TX 78744
USA

Call Ambion to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-512-795-4221
Customer Service: 512-651-0200
Fax Number: 512-651-0201
Web Site: http://www.ambion.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. DNase I (RNase-free) (2 U/l) from Ambion
2. QIAGEN RNase Inhibitor (7500 U) from QIAGEN
3. ShortCut RNase III from New England Biolabs
4. RNase H from Roche Applied Science
5. RNase-Free Dnase from BD Biosciences Pharmingen
6. RQ1 RNase-Free DNase from Promega
7. DNase I, RNase-free; special quality for molecular biology from Roche Applied Science
8. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
9. SuperScript II RNase H- Reverse Transcriptase from Invitrogen
10. RNase Inhibitor from Applied Biosystems
11. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
...
CD45/CD34 combination 50 tests...
... polyclonal to ThPok ( Abpromise for all ... peptide conjugated to KLH derived from within residues ... (Note: the amino acid sequence is proprietary) ... Entrez Gene ID: 51043 ...
Biology Products:
(Date:12/18/2018)... ... December 18, 2018 , ... CP Merritt is a national champion ... for many years however in 2006, he had a medical setback that caused him ... that he suffered from cartilage degeneration in his right rear fetlock. Such an ...
(Date:12/13/2018)... ... December 13, 2018 , ... Study Protocol Summary of ... (with Ethical e-CRF®): IGA first assessment performed at the site., 3 - Three photos ... Staff Controls Photo anonymization in BOX., 5 - Photos moved to eAdjudication® and submitted ...
(Date:12/13/2018)... ... December 12, 2018 , ... Royal Biologics, an ... has announced the launch of Maxx-Cell, the world's most advanced bone marrow aspiration ... aspirating a patients autologous bone marrow cells. Maxx™-Cell however does not require centrifugation ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... ... was adopted from a local shelter when he was around two years old. According ... weeks after he was adopted, he tore his right cruciate ligament. Though he had ... such a traumatic injury. , Sure enough, when Rascal was about nine years old, he ...
(Date:1/8/2019)... DENVER (PRWEB) , ... January 07, 2019 , ... ... comprised of its members into Noninvasix. This represents the second investment AngelMD has ... neonatal mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, ...
(Date:1/4/2019)... TRIANGLE PARK, N.C. (PRWEB) , ... January 04, ... ... consulting organization, is pleased to welcome Ted Hoffman to the firm. Ted will ... 20 years of experience working in and providing consulting services to the pharmaceutical ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, ... cancer, today announced the founding of a scientific and medical advisory board (SMAB). ... key leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB ...
Breaking Biology Technology: